Abbott Laboratories News

ABBOTT PARK, Ill., June 1, 2012 /PRNewswire/ -- Abbott was once again named one of the "Best Places to Work in Industry" by The Scientist magazine.

Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=NVS&cob=ABT . Brighton Markets is releasing new coverage on Novartis AG for its current position within the healthcare industry.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Merck & Co., Inc.

Apple Inc. : Jim Cramer ranked this stock a Buy . The stock closed at $579.17, its 52-week high is $644.00, and its 52-week low is $310.50. Abbott Laboratories : Jim Cramer ranked this stock a Buy .

Jim Cramer recently released Cramer's Top Dividend Stocks 2012 in which he picked 16 dividend plays for a tough economy.

Abbott Laboratories is a company that is involved in developing and manufacturing healthcare products.

From the Department of Obstetrics, Gynecology, and Reproductive Sciences , R.E.G., Magee-Womens Research Institute , Department of Epidemiology , Department of Environmental and Occupational Health , and Clinical and Translational Research , University of Pittsburgh, Pittsburgh, PA; Abbott Laboratories , Abbott Park, IL.

Last October, shortly after Abbott Laboratories announced that it would be splitting itself up, I published " Abbott: Still a Dividend Growth Stalwart ?" I examined the official announcement, an 81-slide presentation about the split, and other materials.

Grace Groner is a late millionaire you don't know. Her net worth was $7 million when she died in 2010.

Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men with low levels of testosterone.

The pharmaceuticals industry is a defense play, just like the food and beverages industry, in terms of sensitivity and market beta.

Abbott Laboratories ' bid to expand use of its best-selling arthritis treatment Humira to ulcerative colitis patients is being delayed by U.S. regulators.

Business Week Article States That Manufacturer of Depakote Agrees to Pay $1.6 Billion to Settle Government Investigations, Consumer Justice Foundation Reports The CJF further reports that Business Week has published an article stating that Abbott Laboratories, the manufacturer of Depakote, has agree to pay a $1.6 billion settlement to the ... (more)

Abbott is introducing a new option for picky eaters' routine with PediaSure SideKicks Clear , a refreshing clear nutritional beverage that helps balance out the diet of those picky eaters who are growing fine, but still may be missing nutrients.

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the Proshares Ultra S&P500 where we have detected an approximate $54.3 million dollar inflow - that's a 4.6% increase week over week in outstanding units .

Citing "enhanced prospects for new drug approvals and a favorable outlook for mergers and acquisitions," S&P Capital IQ extolled the virtues of investing in the biotechnology sector and highlighted several ETFs offering exposure to biotech stocks in a new research note.

Indian drugmaker Piramal Healthcare has agreed to buy a U.S.-based healthcare data provider for $635 million to boost research and development, the company said on Wednesday, a month after it acquired the new molecules division of Germany's Bayer's . Mumbai-based Piramal has been looking to expand its R&D portfolio after it sold its formulations ... (more)

Pfizer's experimental pill for rheumatoid arthritis won the backing of a panel of advisers to the Food and Drug Administration Wednesday.

In a decision that bolsters the pharmaceutical industry, a federal appeals court has ruled that sales reps are not eligible for overtime pay.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia After more than a dozen years, Abbott Laboratories is no longer operating under a consent decree.